The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

OBJECTIVE: 11-β-hydroxysteroid dehydrogenase type 1 (11βHSD1) converts inactive cortisone into active cortisol, thereby amplifying intracellular glucocorticoid action. The efficacy and safety of the 11βHSD1 inhibitor INCB13739 were assessed when added to ongoing metformin monotherapy in patients wit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Rosenstock, Julio, Banarer, Salomon, Fonseca, Vivian A., Inzucchi, Silvio E., Sun, William, Yao, Wenqing, Hollis, Gregory, Flores, Robert, Levy, Richard, Williams, William V., Seckl, Jonathan R., Huber, Reid
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Diabetes Association 2010
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2890352/
https://ncbi.nlm.nih.gov/pubmed/20413513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-2315
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller